SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
3469693
Source:
http://linkedlifedata.com/resource/pubmed/id/3469693
Search
Subject
(
52
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0012931
,
umls-concept:C0017296
,
umls-concept:C0027468
,
umls-concept:C0086418
,
umls-concept:C0162458
,
umls-concept:C0425382
,
umls-concept:C0442711
,
umls-concept:C1515022
,
umls-concept:C1552961
,
umls-concept:C1707689
pubmed:issue
4
pubmed:dateCreated
1987-4-15
pubmed:keyword
http://linkedlifedata.com/resource/pubmed/keyword/Biomedical and Behavioral Research
,
http://linkedlifedata.com/resource/pubmed/keyword/Genetics and Reproduction
,
http://linkedlifedata.com/resource/pubmed/keyword/Legal Approach
,
http://linkedlifedata.com/resource/pubmed/keyword/NATIONAL INSTITUTES OF HEALTH
,
http://linkedlifedata.com/resource/pubmed/keyword/Points to Consider
,
http://linkedlifedata.com/resource/pubmed/keyword/Recombinant DNA Advisory Committee
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7807151
pubmed:citationSubset
E
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/DNA, Recombinant
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0196-0229
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:pagination
221-42
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:3469693-Advisory Committees
,
pubmed-meshheading:3469693-Clinical Trials as Topic
,
pubmed-meshheading:3469693-DNA, Recombinant
,
pubmed-meshheading:3469693-Disclosure
,
pubmed-meshheading:3469693-Ethical Review
,
pubmed-meshheading:3469693-Ethics Committees, Research
,
pubmed-meshheading:3469693-Federal Government
,
pubmed-meshheading:3469693-Genetic Engineering
,
pubmed-meshheading:3469693-Government Regulation
,
pubmed-meshheading:3469693-Humans
,
pubmed-meshheading:3469693-Information Dissemination
,
pubmed-meshheading:3469693-Informed Consent
,
pubmed-meshheading:3469693-National Institutes of Health (U.S.)
,
pubmed-meshheading:3469693-Patient Selection
,
pubmed-meshheading:3469693-Research Design
,
pubmed-meshheading:3469693-Research Subjects
,
pubmed-meshheading:3469693-Risk Assessment
,
pubmed-meshheading:3469693-United States
pubmed:year
1986
pubmed:articleTitle
National Institutes of Health. Points to consider in the design and submission of human somatic-cell gene therapy protocols. Human Gene Therapy Subcommittee, NIH Recombinant DNA Advisory Committee. Adopted September 29, 1986.
pubmed:publicationType
Journal Article